日, 오미크론 '개량 백신' 예상보다 한달 빠른 9월 중반 접종 추진

2022.08.30 오전 11:29

화이자·모더나, 후생노동성에 백신 승인 신청서 제출
식약처도 개량백신 심사 착수…미국은 다른 행보 보여

13일 오후 경기도 성남시 분당구 SK바이오사이언스 연구소에서 연구원이 국산 1호 코로나19 백신 '스카이코비원'을 들어보이고 있다. 2022.7.13/뉴스1 ⓒ News1 사진공동취재단

본문 이미지 - NEW YORK, NY - NOVEMBER 19: A sign outside of a hospital advertises the COVID-19 vaccine on November 19, 2021 in New York City. On Friday vaccine advisers to the US Centers for Disease Control (CDC) and Prevention voted unanimously in recommending a booster shot of the COVID-19 vaccines for all adults in the United States six months after they finish their first two doses. Spencer Platt/Getty Images/AFP == FOR NEWSPAPERS, INTERNET, TELCOS & TELEVISION USE ONLY == ⓒ AFP=뉴스1 — NEW YORK, NY - NOVEMBER 19: A sign outside of a hospital advertises the COVID-19 vaccine on November 19, 2021 in New York City. On Friday vaccine advisers to the US Centers for Disease Control (CDC) and Prevention voted unanimously in recommending a booster shot of the COVID-19 vaccines for all adults in the United States six months after they finish their first two doses. Spencer Platt/Getty Images/AFP == FOR NEWSPAPERS, INTERNET, TELCOS & TELEVISION USE ONLY == ⓒ AFP=뉴스1

관련 키워드

오미크론 개량형 백신